James “Jake” Schaller is counsel in
the Washington, D.C. office of Hughes Hubbard. Jake represents clients in
numerous complex business disputes across a wide range of industries.
His numerous corporate and
individual clients have praised his responsiveness, poise under pressure, and
ability to distill complicated issues quickly, while keeping them focused on
their ultimate goals.
Jake graduated cum laude from
the University of Notre Dame, where he received a Bachelor of Arts degree. He
earned his Juris Doctor from the University of Maryland Francis King Carey
School of Law, where he graduated magna cum laude and was inducted into the
Order of the Coif.
While at Maryland, Jake
competed on the Moot Court team and was a semifinalist in the school’s Morris
B. Myerowitz Moot Court Competition. He also was an editor for the school’s
Journal of Health Care Law and Policy and wrote an article on synthetic drugs
that was published in the Journal. Upon graduation, he received Maryland’s
Litigation and Advocacy Award and the William P. Cunningham Award for
exceptional achievement and service to the law school.
Prior to attending law school,
Jake was an award-winning sports journalist for several publications including
The Washington Post and The Colorado Springs Gazette.
Highlighted Matters
Ongoing representation of former member of the Board of Directors of a leading pharmaceutical company in a major federal court litigation.
Ongoing representation of plaintiffs in a class action regarding false advertising by a group of pharmaceutical companies.
Successfully represented home builder before Maryland-National Capital Park and Planning Commission in hearing on removal of Conservation II Easement.
Won partial summary judgment on key contractual issue, leading to resolution that allowed client to keep 100 percent of profits from disputed sale of real estate.
Assisted with securing a favorable settlement for owner of technology company in dispute with former partner.
Helped secure removal of trustee of high-value trust and appointment of client as rightful successor trustee.
